Publication Cover
Natural Product Research
Formerly Natural Product Letters
Volume 38, 2024 - Issue 12
112
Views
0
CrossRef citations to date
0
Altmetric
Rapid Communication

Antiviral activity and active components of the leaves from Sabia parviflora Wall. ex Roxb

ORCID Icon, , , , , , , , , , , & ORCID Icon show all
Pages 2151-2154 | Received 08 May 2023, Accepted 12 Jul 2023, Published online: 01 Aug 2023
 

Abstract

Sabia parviflora (SP, “xiao hua qing feng teng” in Chinese) was recorded as an important ethnic medicine to be used for treating viral hepatitis. The antiviral activity of four SP extracts and potent antiviral compounds evaluated with cathepsin L protease (Cat L PR) and HIV-1 protease (HIV-1 PR). UPLC-HRMS was used for identifying the bioactive components. In addition, the possible inhibitory mechanism of the identified compounds on viral protease was further discussed by molecular docking. As a result, four extracts of SP exhibited inhibitory activity of HIV-1 PR and Cat L PR with IC50 range from 0.015 to 0.80 mg/mL. Meanwhile, six compounds inhibited HIV-1 PR with IC50 range from 0.032 to 0.80 mg/mL. Moreover, procyanidin B2 had good affinity for HIV-1 PR and CatL PR protein, respectively. These findings suggest S. parviflora leaves can be used for treating HIV and procyanidin B2 may play a role in antiviral protease.

Graphical Abstract

Disclosure statement

No potential conflict of interest was reported by the authors.

Additional information

Funding

The project was supported by grants from the Science and Technology Planning Project of Guizhou Province [grant no. Qian Ke He Zhi cheng [2020] 4Y213 and Qian Ke He Foundation ZK [2021] General 518], the Innovation Group Project of Guizhou Province [grant no. Qian Jiao He KY [2021] 018], the Association of Natural Science of Foundation of China [grant no. 81760758] and Research Center of Molecular Bioactivity from Traditional Chinese Medicine and Ethnomedicine [grant no. 3411-4110000520364], Shenzhen Fund for Guangdong Provincial High-level Clinical Key Specialties [grant no. SZXK059], and Bright Future Fund for Guangdong Provincial Hospital Pharmacology Research [grant no. 2023A13].

Log in via your institution

Log in to Taylor & Francis Online

PDF download + Online access

  • 48 hours access to article PDF & online version
  • Article PDF can be downloaded
  • Article PDF can be printed
USD 61.00 Add to cart

Issue Purchase

  • 30 days online access to complete issue
  • Article PDFs can be downloaded
  • Article PDFs can be printed
USD 861.00 Add to cart

* Local tax will be added as applicable

Related Research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.